Encompass Health Co. (NYSE:EHC) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund cut its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 4.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,263 shares of the company's stock after selling 2,500 shares during the quarter. New York State Common Retirement Fund owned 0.05% of Encompass Health worth $4,734,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of EHC. Point72 Asset Management L.P. boosted its stake in shares of Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after buying an additional 835,135 shares in the last quarter. Jennison Associates LLC acquired a new position in shares of Encompass Health in the fourth quarter worth $52,094,000. abrdn plc acquired a new position in shares of Encompass Health in the fourth quarter worth $17,846,000. Thrivent Financial for Lutherans raised its holdings in shares of Encompass Health by 26.0% in the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock worth $73,494,000 after acquiring an additional 156,938 shares during the last quarter. Finally, Franklin Resources Inc. raised its holdings in shares of Encompass Health by 22.0% in the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock worth $67,412,000 after acquiring an additional 126,000 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.4 %

EHC stock traded down $0.38 during trading on Monday, reaching $99.76. 419,040 shares of the stock traded hands, compared to its average volume of 650,671. Encompass Health Co. has a 52-week low of $74.27 and a 52-week high of $104.55. The business's 50 day moving average price is $96.42 and its 200-day moving average price is $96.42. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a market capitalization of $10.05 billion, a PE ratio of 22.34, a P/E/G ratio of 2.31 and a beta of 0.90.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is currently 15.25%.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.10% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on EHC. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Barclays lifted their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.